Canna Care Docs

OCTOBER 10, 2024

Drug Enforcement Administration (DEA) will move to reclassify cannabis — a historic shift that could have wide ripple effects across the country. What could the implications be for patients on their medical cannabis journey? Rescheduling would stand to have the largest impact on cannabis research and business taxes.

Patients 111

Patients DEA Research and Development Recreational 111

NORML

NOVEMBER 1, 2022

“Legalizing and regulating cannabis provides for more job opportunities, greater tax revenues, and safe access to high quality products at increasingly affordable prices,” NORML’s State Policy Manager Jax James said. This economic data shows once again why legalization is a preferable policy option over criminal prohibition.".

Legalization 49

Legalization Data Policy Access 49

NORML

APRIL 30, 2020

The call for comments, posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Chronic Pain 337

Chronic Pain Clinical Trials Data Patients 337

Americans for Safe Access

JANUARY 12, 2024

For over 2 decades Americans for Safe Access (ASA) has been advocating for a change in the scheduling of cannabis to recognize its medical use.

Data 220

Data Food Access Cannabis 220

NORML

APRIL 7, 2020

Incidences of the vaping-related lung illness EVALI (e-cigarette or vaping product use-associated lung injury) are primarily concentrated to jurisdictions where adult-use cannabis consumption is prohibited, according to data published in the Journal of the American Medical Association (JAMA) Network Open.

Vaping 282

Vaping Legalization Concentrates Access 282

NORML

FEBRUARY 28, 2020

Patients purchased an estimated $112 million worth of medical cannabis-related products in 2019, according to newly released Maine tax data. The annual revenues related to medical cannabis now total more than the total revenues generated by the sales of blueberries, maple syrup, apples, herring, and oysters combined.

Data 236

Data Patients Retail Programs 236

NORML

MARCH 30, 2020

There is an absence of clinical data supporting the efficacy of CBD as an antiviral agent, according to a systematic literature review published in the journal Cannabis and Cannabinoid Research. However, this data was based solely on preclinical findings. ” — appears online here.

CBD 294

CBD Clinical Trials Data Treatment 294

NORML

APRIL 27, 2020

The Coalition letter focuses on the need for small business access to the SBA relief funds as an avenue to protect the progress that has been made by minority entrepreneurs in the emerging legal cannabis marketplaces. You can read NORML’s factsheet on the racial disparity among arrests here. You can read the full letter below.

Business 304

Business Access Policy Programs 304

NORML

FEBRUARY 26, 2019

While most of the recent media conversation around cannabis and the Super Bowl surrounded the ability for a medical marijuana company’s attempt to air an advertisement, one of the issues raised by various NORML members over the last few weeks has been more focused on the actual well-being of the players themselves.

Access 200

Access Medicine Policy Media 200

NORML

AUGUST 20, 2019

The self-reported use of marijuana by teenagers continues to decline nationally, according to federal data reported by the United States Substance Abuse and Mental Health Services Administration (SAMHSA). By contrast, self-reported cannabis use by older Americans has risen during this same time period. percent to 12.5 percent to 12.5

Marijuana 233

Marijuana Data Access Environment 233

NORML

DECEMBER 29, 2020

According to statewide polling data, 90 percent of Kentucky residents support regulating medical marijuana access. The post States to Watch in 2021: Kentucky appeared first on NORML.

Data 246

Data Access Marijuana Cannabis 246

The Cannigma

APRIL 12, 2023

MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. In September 2021, MoreBetter hosted a self-reported data collection with this CBN tincture offered to participants for free of charge from CBDistillery. Here’s what they found.

Sleep 133

Sleep Data Tincture Research and Development 133

NORML

JANUARY 31, 2019

Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.

Clinical Trials 207

Clinical Trials Chronic Pain Data Treatment 207

NORML

AUGUST 29, 2019

Remarks made today by the United States Surgeon General highlighting “the importance of protecting our nation from the health risks of marijuana use in adolescents and during pregnancy” fail to acknowledge the role that a regulated market can play in mitigating the use of cannabis by potentially high-risk populations.

Education 228

Education Data Retail Environment 228

Cannabis Law Report

JUNE 21, 2021

Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. How to Use the Data. Men were more likely than women to treat pain with cannabis.

Data 105

Data Clinical Trials Research and Development Indica 105

NORML

FEBRUARY 1, 2019

Patients authorized to legally use medical cannabis frequently substitute it in place of benzodiazepines, according to a pair of new studies published this week. According to data compiled by the US Centers for Disease Control, the drug was attributed to over 11,500 overdose deaths in 2017.

Patients 237

Patients Chronic Pain Therapy Data 237

NORML

JULY 2, 2019

Adults who purchase retail cannabis typically report using it to mitigate pain and to improve sleep, and often use it in place of conventional medications, according to data published online today in the Journal of Psychoactive Drugs.

Retail 218

Retail Sleep History Medicine 218

Veriheal

FEBRUARY 21, 2023

As medicinal and recreational cannabis legalization continues to sweep across the United States, a recent study paints a concerning portrait of many states denying or restricting medical marijuana (MMJ) access. Why Do MMJ Patients Use Cannabis? How Do MMJ Restrictions Affect Patients and Doctors?

Access 98

Access Patients Chronic Pain Conditions 98

Cannabis Law Report

DECEMBER 18, 2020

15, 2020 /PRNewswire/ — CME Group, the world’s leading and most diverse derivatives marketplace, today announced that customers can now access hemp … Read More. The post CME Group Adds New Hemp Pricing Data to CME DataMine first appeared on Cannabis Law Report. CHICAGO , Dec.

Data 98

Data Hemp Access Law 98

NORML

MAY 23, 2019

Seniors who report the use of cannabis over the past year say that it improves their overall quality of life, according to survey data published in the journal Gerontology & Geriatric Medicine. years) regarding their cannabis use patterns.

Topical 206

Topical Data Edibles Medicine 206

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo. .”

Clinical Trials 275

Clinical Trials Chronic Pain Cannabinoids Patients 275

NORML

JUNE 10, 2020

The agency’s call for comments, initially posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Chronic Pain 255

Chronic Pain Therapy Patients Topical 255

Cannabis Law Report

DECEMBER 27, 2019

If you thought there was no relationship between cannabis use and technology, consider these stats: the average number of mobile apps being used in a day by current cannabis users are 4. However, the costs of conducting a full-scale clinical trial can be prohibitive, posing barriers to research for cannabis companies.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

Veriheal

DECEMBER 14, 2021

In accordance with this, a new study found that states with legal cannabis markets have been less likely to experience incidences of EVALI, suggesting that properly regulated vape pens are not the problem. An Analysis of Nationwide EVALI Data. ” The study also discovered impacts from other variances in policies across states.

Data 98

Data Vaping Legalization Consumption 98

Americans for Safe Access

MARCH 24, 2020

With everything happening in the news lately, we want to present some scientific data to help medical cannabis patients and adult-use consumers make informed decisions in regard to cannabis products available, product safety, and personal health.

Cannabinoids 247

Cannabinoids Data Safety Patients 247

The Cannigma

JANUARY 16, 2021

Listen & Subscribe: Finding the right cannabis product can be a daunting task for anyone, let alone a new medical patient without any guidance. “That’s not really available in the cannabis industry,” he explained on the Cannabis Enigma podcast. Produced by Elana Goldberg and Michael Schaeffer Omer-Man.

Data 100

Data Research and Development Patients Strains 100

Americans for Safe Access

JANUARY 12, 2024

We are hopeful that the DEA will agree with HHS’ recommendation to change cannabis’ status and that Congress views HHS’ report as a greenlight to move forward with a more comprehensive approach to medical cannabis access.” ASA’s recommendation to FDA for scheduling can be found here.

DEA 130

DEA Media Access Data 130

Cannabis Law Report

AUGUST 23, 2021

Medicinal Cannabis Access Data Dashboard. To improve transparency and data accessibility, the TGA publishes de-identified data on the number of unapproved medicinal cannabis products accessed through the Special Access Scheme (SAS). 19 August 2021.

Data 105

Data Access Medicine Patients 105

NORML

JULY 17, 2019

Members of the United States Senate Committee on Banking, Housing, and Urban Affairs are scheduled to hear testimony next week regarding the need to provide greater access to financial services for state-licensed marijuana-related businesses. ” (Read NORML’s full testimony here.). .”

Banking 192

Banking Marijuana Legislation Access 192

Cannabis Chronicles

MAY 22, 2019

“We’ll hand them an iPad, and ask them to fill out a couple quick surveys,” said Michael McDonell, chair of WSU’s Collaboration on Cannabis Policy, Research and Outreach. Some of the outcomes we’re interested in looking at, is what kind of cannabis are they using? The tribe is scheduled to fund the research project for a year.

Medicine 140

Medicine Research and Development Data Collective 140

NORML

JANUARY 15, 2020

Members of the House Energy and Commerce Subcommittee on Health today held a legislative hearing, “ Cannabis Policies for the New Decade ,” during which they considered multiple legislative bills aimed at amending federal cannabis laws. He continued: “The fact of the matter is that legalization and regulation work.

Policy 197

Policy DEA Legislation Data 197

NORML

MAY 21, 2019

The administration of oral CBD reduces cue-induced cravings and anxiety in subjects with a history of heroin use, according to clinical data published in The American Journal of Psychiatry. ” In observational models , patients with legal access to cannabis typically reduce or eliminate their use of opioids.

Clinical Trials 197

Clinical Trials CBD History Data 197

Cannabis Cheri

APRIL 1, 2022

Cannabis and Keto, Keto and cannabis. Health, fitness, and cannabis enthusiasts are all singing the praises of combining cannabis and the keto diet. However, when it comes to cannabis and the keto diet, many people claim they actually enhance each other’s health benefits. 6 Keto and Cannabis Edibles 6.1

Edibles 203

Edibles Cannabis Cannabinoids Oil 203

Canna Law Blog

MAY 25, 2019

Most states’ regulated cannabis regimes require licensed cannabis companies to use seed-to-sale track-and-trace software. Our California cannabis attorneys frequently assist clients with track-and-trace compliance and preparation. While loss of access to the entire METRC system could happen, it’s probably not very likely.

Data 94

Data Seed-To-Sale Access Compliance 94

SpeedWeed

JULY 18, 2021

All across the US, lawmakers are scrambling to pass laws that would cap the strength of high-potency cannabis concentrates, arguing that high THC levels pose a serious health risk. One group used cannabis flower with at least 20 percent THC content and over 0.7

Concentrates 98

Concentrates Data THC CBD 98

Illinois News Joint

OCTOBER 9, 2024

Last week, Illinois officials released the Annual Cannabis Report for Fiscal Year 2024. In coordination with the Cannabis Regulation Oversight Office (CROO) and legislators, IDFPR has begun efforts to allow medical patients to receive their medical tax rate at any dispensary in Illinois. In addition, IDFPR lists as its No.

Dispensary 116

Dispensary Patients Access Legislation 116

Project CBD

AUGUST 6, 2019

Over 200 scientists from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpiblished data. None of the participants had been using any cannabinoid-based products prior to this study.

CBD 222

CBD Blood Pressure Research and Development Cannabinoids 222